Gene Query: UTP4

Dataset Description Geneva Score
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 54.62
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 39.55
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 32.96
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 30.17
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 29.83
ETV7 and interferon response 29.83
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 28.05
Global gene expression profile of dasatinib-resistant RCH-ACV cells 25.0
The interplay between SOX4 and SMAD3 in the context of breast cancer 22.82
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 22.24
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 22.23
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 22.23
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 21.0
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 20.98
Lysine benzoylation is a novel histone mark 20.65
Lysine benzoylation is a novel histone mark [RNA-seq] 20.65
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 20.41
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 20.16
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 19.56
RNA-Seq analysis of breast cancer cells after shikonin treatment 19.51
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 19.27
AUF-1 affected genes in human skin cells 19.26
The landscape of alternative splicing in aggressive prostate cancers 19.19
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 18.35
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 18.35
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 18.11
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 17.36
Regulating Interleukin-2 activity with engineered receptor signaling clamps 17.31
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.86
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.86
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 16.84
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 16.33
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 16.16
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 15.77
Identification of Sin3B regulated genes during quiescence 15.75
FOXD3 is a novel tumor suppressor in lung cancer 15.5
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 15.49
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 15.28
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 15.13
G-quadruplex structures mark human regulatory chromatin 14.87
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 14.82
A549 cells and MSR-A549 cells 14.82
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 14.75
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 14.69
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 14.48
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 14.41
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 14.38
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 14.34
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 14.31
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 14.31
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 14.24
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 14.24
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 14.15
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 13.97
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 13.93
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 13.89
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 13.87
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 13.7
RNA-seq analysis of RALD iPSCs after in vitro differentiation 13.44
RNA-seq analysis of BAP1-depleted uveal melanoma cells 13.42
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 13.38
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 13.22
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 12.97
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 12.87
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 12.82
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 12.64
Transcriptomic analyssis following EHMT1/2 inhibition 12.49
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 12.42
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 12.17
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 12.17
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.12
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 12.01
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 11.97
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 11.97
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 11.96
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 11.95
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 11.77
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 11.77
Nucleoporin-mediated regulation of cell identity genes 11.72
Tracking of dCas9-methyltransferase footprints 11.63
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 11.62
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 11.62
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 11.62
Disruption of the exocyst induces podocyte loss and dysfunction 11.57
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 11.5
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 11.47
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.47
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 11.44
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 11.36
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 11.22
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.19
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 11.15
SETBP1-WT and SETBP1-G870S epigenetic landscapes 11.14
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 11.14
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.1
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 10.84
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 10.81
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.74
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 10.73
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 10.73
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 10.72
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 10.64
An integrative analysis of non-coding regulatory DNA variations associated with autism 10.62
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.59
single cell RNA-seq from GM12878 (ENCSR673UIY) 10.57
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 10.55
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 10.55
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.45
RNAseq Analysis in glioblastoma cells treated with Mepazine 10.41
RNAseq of HEK293 cells after Chtop knockdown 10.41
Co-transcriptional loading of RNA export factors shapes the human transcriptome 10.41
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 10.34
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.32
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 10.18
Cell responses to dysregulated VZV-induced cell-cell fusion 10.16
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 10.14
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 10.12
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 10.08
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 10.08
Trans-differentiation of human adult peripheral blood T cells into neurons 10.06
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 10.06
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 9.98
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.96
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 9.93
RIG-I and MDA5 fRIP during KSHV lytic reactivation 9.9
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 9.88
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 9.83
N6-methyladenine DNA Modification in Glioblastoma 9.83
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.81
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.81
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 9.78
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 9.75
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 9.75
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.65
EWSR1 influences alternative splicing through direct and indirect mechanisms 9.64
Transcriptome of activated human and mouse MAIT cells 9.56
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 9.51
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 9.51
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.48
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.43
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 9.42
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.37
Genetic-to-epigenetic Therapy for Pancreatic Cancer 9.37
Genome wide expression change by RNF168 knocking down in NEC cells 9.26
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.23
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 9.21
Effect of Hotair overexpression in human breast cancer cell lines 9.13
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 9.12
Overexpression and knockdown experiment for circCSNK1G3 9.09
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 9.09
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.06
MeRIP-seq for heat shock in B-cell lymphoma cells 9.06
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 9.05
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 9.05
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.05
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.05
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 9.03
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 9.03
LNCaP treated with iBET 9.03
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 9.01
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 9.01
Regulation of highly expressed hCINAP on translatome 8.99
K562 polyA RNA-Seq 8.93
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 8.92
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.91
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.86
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 8.85
Single-nucleotide-resolution mapping of HBV promoters using CAGE 8.84
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.78
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 8.77
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 8.77
LncRNA-GAS5 negative regulation of YAP-target genes expression 8.76
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 8.71
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.7
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 8.7
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 8.69
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.64
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.64
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 8.63
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 8.63
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 8.63
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 8.61
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.59
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 8.57
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.57
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 8.56
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 8.53
RNA-seq analysis of differentiating human erythroblasts 8.51
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 8.5
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 8.48
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 8.4
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 8.33
Primary human trophoblast from term placenta 8.33
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 8.29
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.23
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 8.22
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 8.21
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.18
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 8.16
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 8.13
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 8.09
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 8.09
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.08
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.08
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 8.03
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 8.03
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.98
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 7.86
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.72
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 7.71
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.69
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 7.63
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 7.61
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.59
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 7.56
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 7.56
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 7.54
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 7.53
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 7.53
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 7.5
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 7.5
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.49
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 7.49
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.46
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.43
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 7.39
Effect of FGF13 depletion on the H460 cell line 7.38
High-throughput sequencing of pluripotent cells 7.34
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.34
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 7.34
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.3
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 7.29
JunB control of keratinocyte-mediated inflammation [RNA-seq] 7.25
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 7.25
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.16
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.16
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 7.15
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 7.14
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 7.14
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 7.12
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 7.08
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 7.08
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.0
Regulation of protein translation during mitosis 6.97
Differetially expressed genes after hTR overexpression in U2OS cells 6.96
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 6.93
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.9
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 6.9
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.88
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.87
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.86
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.86
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 6.85
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 6.84
Dynamic 3D chromosomal landscapes in acute leukemia 6.84
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 6.82
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 6.79
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 6.77
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 6.76
Primary Human B-cell Temporal Response to CD40L Stimulation 6.74
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.71
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.64
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 6.62
MCF-7 as a model for functional analysis of breast cancer risk variants 6.61
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.6
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.57
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 6.57
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 6.57
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.54
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.53
RNAseq Study in CC-671 Treated Cal-51 Cells 6.46
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.38
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.36
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.36
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 6.35
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.34
Gene expressions of H9s in different culture systems 6.34
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 6.32
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 6.32
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 6.22
IMP3 regulated gene expression in breast cancer cells 6.19
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 6.1
RNAseq of T-ALL upon long non coding rna purturbation 6.09
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 6.07
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.07
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 6.03
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 6.0
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.99
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.97
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.97
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.93
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.9
Seletive inhibition of CDK9 in DLBCL cell lines 5.84
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.72
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.71
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 5.68
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.68
The Genetic Landscape of Diamond-Blackfan Anemia 5.63
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 5.51
Ro60-knockout cells 5.46
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.46
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.46
Energy Metabolism during Anchorage-Independence 5.46
RNA-seq of RKO cells with cTAZ KO or putback 5.46
Noncoding regions are the main source of targetable tumor-specific antigens 5.45
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.42
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.42
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.4
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.4
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 5.35
Unique features and clinical importance of acute alloreactive immune responses 5.33
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.33
A map of gene expression in neutrophil-like cell lines 5.29
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.29
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.29
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 5.26
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.19
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 5.07
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 5.04
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 5.03
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.01
The cohesin complex prevents Myc-induced replication stress 4.99
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.99
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 4.98
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.87
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.86
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.86
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.83
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.83
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.82
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.8
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.79
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 4.79
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.67
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.63
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.58
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.54
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.54
RNA seq_PDX2_SHP099 4.52
RNA sequencing of human mammary epithelial cells 4.52
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.52
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.51
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.51
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.51
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 4.46
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.37
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.33
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.31
Gene expression analysis of human liver progenitor-like cells in culture 4.29
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 4.18
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 4.18
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.17
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 4.09
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 4.05
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.99
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.99
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.96
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.96
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.93
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.85
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.83
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.82
KSDM1b Role in Ewing Sarcoma 3.82
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.8
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.79
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.77
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.76
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.67
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.64
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.6
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.59
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.59
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.57
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.54
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.53
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.39
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.38
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.37
RNA seq with AML (NB4) cells upon FTO inhibition 3.33
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.29
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.25
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.23
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.19
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 3.19
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.17
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 3.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.09
FOXP2's impact on the primate transcriptome 3.02
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 3.02
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.01
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.97
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.97
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.94
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.94
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.91
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 2.88
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.78
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.78
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.76
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.74
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.74
Iron response of HepG2 cells 2.69
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.63
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.61
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.55
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 2.54
Function and hormonal regulation of GATA3 in human first trimester placentation 2.52
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.51
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 2.49
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.42
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.42
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.42
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.4
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.4
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.36
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.36
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.33
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.33
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.33
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.33
CD73 knockdown effect in pancreatic cancer cell lines 2.29
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.16
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.16
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.15
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 2.1
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.09
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.09
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 2.07
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.06
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.99
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.98
Polarized B -cell functions 1.98
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.97
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.97
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.95
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.93
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.8
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.79
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.78
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.72
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.71
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.68
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.66
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.65
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.62
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.62
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.56
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.55
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.44
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.43
Gene expression changes due to PARP knockdown in human cells 1.3
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.21
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.19
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.17
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.1
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.03
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 1.01
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.92
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.89
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.85
SF3B1 Degron knockdown RNA-seq 0.81
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.79
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.79
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.68
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.68
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.66
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.65
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.63
Transcriptome-wide response to synthetic chromatin protein PcTF 0.61
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.61
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.59
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.59
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.58
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 0.56
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.54
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.54
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.53
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.5
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.44
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.43
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.42
Myc activation coordinates gene transcription and protein translation responses 0.37
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.37
Regulation of hypoxia-inducible factor activity by ZMYND8 0.36
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.34
EGR1-controlled transcriptome of T HESCs 0.32
Human Treg IL-12 stimulation 0.32
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.26
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.24
Ribosomal protein RPL26 is the principal target of UFMylation 0.23
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.21
RNA seq analysis of human Fetal and adult derived Enterospheres 0.17
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.1
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.1
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.02
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation